Skip to main content
OpenTrials

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,259 public trials 4,410 recruiting studies
Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

Project: Every Child for Younger Patients With Cancer

NCT02402244

Conditions
Adrenal Gland Pheochromocytoma, Bone Marrow Diseases, Carcinoma, +59 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
View all 279 locations
View Trial Details
Recruiting

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

NCT06698796

Conditions
Connective Tissue Diseases, Dermatomyositis, Muscular Diseases, +7 more
Locations
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale Glendale, Arizona, United States
  • Nerve & Muscle Center of Texas Houston, Texas, United States
  • Rheumatology & Pulmonary Clinic Beckley, West Virginia, United States
  • Centro de Investigaciones Médicas Tucuman SAN M. de Tucuman, Tucumán Province, Argentina
View all 26 locations
View Trial Details
Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details
Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

NCT07102381

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Oncology Institute Long Beach, California, United States
  • Cancer & Blood Research Center Los Alamitos, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
View all 35 locations
View Trial Details
Recruiting

A Registry-study of ELZONRIS in Participants With BPDCN

NCT07785154

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Medical University Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz Krankenhaus der Elisabethinen Linz Linz, Austria
  • Salzburg Cancer Research Institute (SCRI) Salzburg, Austria
  • Medizinische Universitat Wien, Department for Internal Medicine I, Division of Hematology and Haemostaseology Vienna, Austria
View all 41 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
  • Florida Cancer Specialists /ID# 261569 Sarasota, Florida, United States
View all 54 locations
View Trial Details
Recruiting

ETHAN - ET for Male BC

NCT05501704

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

NCT07053800

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • State University of New York Upstate Medical Center (SUNY) Syracuse, New York, United States
  • Texas Transplant Institute San Antonio, Texas, United States
  • University General Hospital ATTIKON Athens, Greece
  • University General Hospital of Patras Pátrai, Greece
View all 15 locations
View Trial Details

Related conditions